Huaxia Eye Hospital Group Co.,Ltd. (SHE:301267)
China flag China · Delayed Price · Currency is CNY
14.96
-0.13 (-0.86%)
Oct 29, 2026, 4:00 PM EDT

Huaxia Eye Hospital Group Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
473.15440.65428.64665.93513.82454.92
Depreciation & Amortization
322.34322.34309.4274.36274.11265.64
Other Amortization
79.6479.6468.9458.549.0550.55
Loss (Gain) From Sale of Assets
-2.46-2.46-3.49-11.28-1.85-0.1
Asset Writedown & Restructuring Costs
7.67.612.036.150.461.88
Loss (Gain) From Sale of Investments
-37.3-37.3-65.76-87.46-14.5-8.73
Provision & Write-off of Bad Debts
5.085.0811.8611.313.54.36
Other Operating Activities
72.9642.7446.7950.9634.5338.05
Change in Accounts Receivable
19.6619.66330.57-61.85-69.24-12.08
Change in Inventory
-7.92-7.9256.96-33.06-31.23-18.74
Change in Accounts Payable
18.6918.69-363.65108.834.0112.95
Change in Other Net Operating Assets
----0.775.16
Operating Cash Flow
930.3867.58820.3961.24769.98798.02
Operating Cash Flow Growth
10.14%5.76%-14.66%24.84%-3.51%35.11%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-202.58-231.99-279.59-448.43-235.31-173.63
Sale of Property, Plant & Equipment
5.153.812.371.723.561.79
Cash Acquisitions
-217.19-301.15-421.411.82-10.31-
Divestitures
--1.5628.55--
Investment in Securities
-604.32-608.06-132.842,247-2,795-2.02
Other Investing Activities
441.6461.1682.4278.21-6.11
Investing Cash Flow
-577.3-1,076-747.51,909-3,037-167.74

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-60--26.13-
Long-Term Debt Repaid
--480.59-195.04-144.66-143.14-122.43
Lease Payments
-205.91-205.91-173.8-143.64-143.14-122.43
Net Debt Issued (Repaid)
-444.69-420.59-195.04-144.66-117.01-122.43
Issuance of Common Stock
---2.13,053-
Repurchase of Common Stock
-1.37-1.37-199.65---
Common Dividends Paid
-222.67-258.07-91.71-156.8--0.16
Other Financing Activities
-20.89-88.12-19.75-5.13-284.65-57.99
Financing Cash Flow
-689.62-768.15-506.15-304.492,651-180.58

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash Flow
-336.62-976.8-433.362,566384.16449.69

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
727.72635.59540.71512.81534.68624.38
Free Cash Flow Growth
16.44%17.55%5.44%-4.09%-14.37%46.11%
Free Cash Flow Margin
17.29%15.36%13.43%12.78%16.54%20.38%
Free Cash Flow Per Share
0.860.760.640.610.700.83
Levered Free Cash Flow
926.19552.62464.23425.75447.72475.76
Unlevered Free Cash Flow
955.51581.97492.43449.53471.7499.27
Free Cash Flow After Leases
521.81429.68366.91369.17391.54501.95

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
2.922.920.410.520.5-
Cash Income Tax Paid
237.41226.28258.37200.68170.18173.68
Change in Working Capital
9.289.2811.88-7.24-89.12-8.55